Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients

European Respiratory Journal

Volumn 44, Issue 3, 2014, Pages 802-805

  Tiringer, Kerstin ^a   Treis, Angela ^b   Kanolzer, Stefan ^a   Witt, Carina ^a   Ghanim, Bahil ^c   Gruber, Saskia ^a   Schmidthaler, Klara ^a   Renner, Sabine ^a   Dehlink, Eleonora ^a   Nachbaur, Edith ^a   Frischer, Thomas ^a   Klepetko, Walter ^c   Akdis, Cezmi A ^b   Szépfalusi, Zsolt ^a   Eiwegger, Thomas ^a  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 8; HMGB1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MESSENGER RNA;

ADAPTIVE IMMUNITY; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FORCED VITAL CAPACITY; HELPER CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LETTER; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; LUNG DISEASE; LUNG LAVAGE; METABOLISM; TH2 CELL;

ADAPTIVE IMMUNITY; BRONCHOALVEOLAR LAVAGE FLUID; CYSTIC FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKINS; LUNG DISEASES; RNA, MESSENGER; TH2 CELLS;

EID: 84907362644     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00046614     Document Type: Letter

References (12)

1. Tiringer K, Treis A, Fucik P, et al. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2013; 187: 621-629.
2. Liou TG, Adler FR, Keogh RH, et al. Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. PLoS One 2012; 7: e42748.
3. Hirsiger S, Simmen HP, Werner CM, et al. Danger signals activating the immune response after trauma. Mediators Inflamm 2012; 2012: 315941.
4. Akdis M, Burgler S, Crameri R, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011; 127: 701-721.e70.
5. Roussel L, Farias R, Rousseau S. IL-33 is expressed in epithelia from patients with cystic fibrosis and potentiates neutrophil recruitment. J Allergy Clin Immunol 2013; 131: 913-916.
6. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
7. Yanai H, Ban T, Taniguchi T. High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol 2012; 33: 633-640.
8. Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165: 2950-2954.
9. Rowe SM, Jackson PL, Liu G, et al. Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med 2008; 178: 822-831.
10. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-1221.
11. Brazova J, Sediva A, Pospisilova D, et al. Differential cytokine profile in children with cystic fibrosis. Clin Immunol 2005; 115: 210-215.
12. Hartl D, Griese M, Kappler M, et al. Pulmonary Th2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 2006; 117: 204-211.